Skip to content
⌘KStart free
AI InfrastructureDefenseQuantumAll studies →

Biotech catalyst calendar

registry pull 2026-08-19

Primary-completion dates that listed drug and biotech companies filed with ClinicalTrials.gov. They are the sponsor's own estimated windows, revised as a study runs — not announcement dates. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

upcoming primary completions across every covered company, by month sources →

Upcoming readout windows

next 90 days · by month

370 studies across 145 companies, in the next 90 days.

August 2026 98

TickerStudyPhaseStatusPrimary completionUpdated
AMGNA Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease ActivityNCT06104124Phase 3Active, not recruiting2026-08-192026-01-16
BMRNStudy of BMN 349 Single Dose in PiZZ and PiMZ/MASH Adult ParticipantsNCT06738017Phase 1Active, not recruiting2026-08-192026-05-06
ORGOA Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot UlcersNCT06618612Not applicableRecruiting2026-08-192025-04-04
SYREA Study of SPY002-091 in Healthy VolunteersNCT06672718Phase 1Active, not recruiting2026-08-192026-06-12
AZNStudy Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an IleostomyNCT06681324Phase 2Active, not recruiting2026-08-202026-06-01
AZNProspective Observational Multicenter Study of Patients With AH and CKD Markers in Kazakhstan (PROGRESS-CKD)NCT06744335—Active, not recruiting2026-08-202026-07-08
SNYRSV Immunisation Status in Queensland (Australia)NCT07615192—Recruiting2026-08-202026-07-31
NVOA Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral NeuropathyNCT06797869Phase 2Active, not recruiting2026-08-212025-12-05
PFEA Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the Body in Healthy AdultsNCT06965465Phase 1Active, not recruiting2026-08-212026-07-23
REGNA Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement TherapyNCT05568459—Active, not recruiting2026-08-212026-08-07
PFEA Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid TumorsNCT05262400Phase 1/2Active, not recruiting2026-08-232024-11-18
AZNA Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced DiseaseNCT04711252Phase 3Active, not recruiting2026-08-242025-10-14
BIIBA Study to Learn More About How Zuranolone Affects Postpartum Depression Symptoms in Participants Who Took it Within 1 Year After The End of Their PregnancyNCT07047820—Recruiting2026-08-242025-08-03
REGNA Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With SurgeryNCT06161441Phase 2Active, not recruiting2026-08-242026-08-10
CLRBDose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and SarcomasNCT03478462Phase 1Active, not recruiting2026-08-252026-03-18
SNYA Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' DiseaseNCT06984627Phase 2Recruiting2026-08-252026-07-07
AMGNEffect of Maridebart Cafraglutide on the Heart's Electrical ActivityNCT07229157Phase 1Active, not recruiting2026-08-262026-01-23
SNYTeplizumab in Pediatric Stage 2 Type 1 DiabetesNCT05757713Phase 4Active, not recruiting2026-08-272026-01-30
AZNA Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLCNCT04995523Phase 1/2Active, not recruiting2026-08-282026-07-14
AZNA Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy ParticipantsNCT07534592Phase 1Active, not recruiting2026-08-282026-06-24
BSXSpaceIT Hydrogel System for Perirectal SpacingNCT06451614Not applicableActive, not recruiting2026-08-302026-08-12
GENBStudy to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult ParticipantsNCT06920693Phase 1Active, not recruiting2026-08-302025-12-05
MSLEAn Open-label Long-term Follow-up Study of SAT-3247 for Participants With Duchenne Muscular Dystrophy Including Those Who Participated in SAT-3247-CL-101NCT06867107Phase 2Enrolling by invitation2026-08-302026-04-23
PFEMagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)NCT06152575Phase 3Recruiting2026-08-302026-08-14
PFEA Study to Learn About Study Medicine Lorlatinib, as a First-line Treatment in Chinese Adults With ALK-positive a/mNSCLCNCT07556549—Active, not recruiting2026-08-302026-08-10
TELAA Retrospective Assessment of OviTex PRS (OviTex)NCT05736848—Active, not recruiting2026-08-302026-08-18
4151.TStudy to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular DegenerationNCT06116890Phase 2Active, not recruiting2026-08-312025-10-30
4151.TStudy to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular EdemaNCT06116916Phase 2Active, not recruiting2026-08-312025-10-30
4568.TTrastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)NCT04704934Phase 3Active, not recruiting2026-08-312026-05-27
ABBVA Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid TumorsNCT02099058Phase 1Active, not recruitingAug 20262025-08-14
ABBVA Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.NCT03539744Phase 3Active, not recruitingAug 20262025-06-19
ABBVRGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD)NCT04514653Phase 2Active, not recruitingAug 20262026-02-27
ABBVA Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to DupilumabNCT06389136Phase 3RecruitingAug 20262026-07-06
ABBVA Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult ParticipantsNCT07032597Phase 3Active, not recruitingAug 20262025-08-14
ABBVA Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye DiseaseNCT07284381Phase 3Active, not recruitingAug 20262026-06-17
ACRSATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic DermatitisNCT07011706Phase 2Active, not recruitingAug 20262026-03-25
AKBATo Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center HemodialysisNCT06901505Phase 3Active, not recruitingAug 20262026-02-23
ANROALTO-100 in Bipolar Disorder With Depression (BD-D)NCT06656416Phase 2RecruitingAug 20262025-07-16
AVIRDrug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or MethadoneNCT07314346Phase 1RecruitingAug 20262026-07-16
AZNA Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in BrazilNCT06008353—Active, not recruiting2026-08-312024-12-19
AZNBoosting Regional Integration for COP D Care Through Guided Implementation and Audit of Post Exacerbation Transition BundleNCT06646419—Active, not recruiting2026-08-312026-08-13
BIVINE3107 in Adults With Neurological Symptoms of Long COVIDNCT06847191Phase 2Active, not recruitingAug 20262026-05-29
BLCOA Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Trial ParticipantsNCT07717918Phase 1RecruitingAug 20262026-07-21
BMRNRapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to PalynziqNCT06780332Phase 4Active, not recruitingAug 20262026-04-03
BMYA Phase 1 Study of Navlimetostat Tablet FormulationsNCT07544628Phase 1Recruiting2026-08-312026-06-24
BSXRespiration Measured Via End-tidal CO2 and Spirometry Study (RESPI)NCT07537478—RecruitingAug 20262026-08-12
CADLA Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene BesadenovecNCT07332000Phase 2RecruitingAug 20262026-03-20
CINPHA.STA Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)NCT07037875Phase 3Active, not recruitingAug 20262026-08-04
CORTRelacorilant in Combination With Different Treatment Regimens in Patients With Gynecological CancersNCT06906341Phase 2RecruitingAug 20262026-07-16
CORTEvaluation of Miricorilant on Liver Fat in Patients With MASLDNCT06947304Phase 1Active, not recruitingAug 20262026-07-30
CRISCA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)NCT03328078Phase 1/2RecruitingAug 20262026-04-16
CYTKA Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)NCT06081894Phase 3Active, not recruitingAug 20262026-08-05
ENSCPF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)NCT06602271Phase 3RecruitingAug 20262026-01-22
EXELA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid TumorsNCT03845166Phase 1Active, not recruiting2026-08-312024-11-19
GEHCData Collection of New Spectral CT Imaging MethodNCT07661706—RecruitingAug 20262026-06-22
GILDStudy of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01NCT06727565Phase 2Active, not recruitingAug 20262026-03-02
GKOSSafety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery AloneNCT06848946Phase 4RecruitingAug 20262026-01-21
GPCRAleniglipron Phase 2 Body Composition StudyNCT07169942Phase 2Active, not recruitingAug 20262026-03-03
HLNClinical Study to Investigate the Antihypersensitivity Efficacy of a Novel DentifriceNCT07215767Phase 3Active, not recruitingAug 20262026-06-16
HROWStudy Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal InjectionsNCT07456826Phase 4Enrolling by invitationAug 20262026-04-07
IGCClinical Trial on Agitation in Alzheimer's DementiaNCT05543681Phase 2RecruitingAug 20262026-05-20
INBSInterference and Stability Evaluation of the Intelligent Fingerprinting Drug Screening SystemNCT07758907Not applicableEnrolling by invitationAug 20262026-08-11
IPN.PAA Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial LinesNCT04821089Phase 1/2Active, not recruiting2026-08-312026-07-28
ISRGA Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 RobotNCT06879912—RecruitingAug 20262026-02-25
IVVDStudy of VYD2311 for the Prevention of COVID-19NCT07298434Phase 3Active, not recruitingAug 20262026-06-10
IVVDSafety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 VaccineNCT07655180Phase 3RecruitingAug 20262026-06-17
KMBTampon Safety-in-Use StudyNCT07561905Not applicableRecruiting2026-08-312026-08-10
KODA Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAKNCT06556368Phase 3Active, not recruitingAug 20262026-04-29
KPTISelinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial CarcinomaNCT05611931Phase 3Active, not recruitingAug 20262026-05-29
KURASafety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid LeukemiaNCT06001788Phase 1RecruitingAug 20262026-04-14
KYTXKYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus NephritisNCT05938725Phase 1/2Active, not recruitingAug 20262025-10-29
LLYA Study of LY3971297 in Healthy ParticipantsNCT06148272Phase 1Active, not recruitingAug 20262026-07-16
LLYEffect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)NCT06260722Phase 3Active, not recruitingAug 20262026-04-13
LLYComparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made Available in the Body, Alone and in the Presence of a Drug That Reduces Stomach AcidNCT06916143Phase 1Active, not recruitingAug 20262026-07-16
LLYA Study of LY3867070 in Healthy ParticipantsNCT07021547Phase 1RecruitingAug 20262026-06-03
LLYA Study of the Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver ImpairmentNCT07165002Phase 1RecruitingAug 20262025-12-04
LLYA Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With Alzheimer's DiseaseNCT07254234—Not yet recruitingAug 20262025-11-28
LLYA Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes MellitusNCT07313813Phase 1Active, not recruitingAug 20262026-04-16
LLYA Study of Remternetug (LY3372993) in Healthy Chinese ParticipantsNCT07346495Phase 1Active, not recruitingAug 20262026-06-17
LLYA Study of Eltrekibart (LY3041658) in Healthy ParticipantsNCT07545590Phase 1RecruitingAug 20262026-06-23
MANESafety and Efficacy of VDPHL01 in Males and Females With AGANCT06527365Phase 2Active, not recruitingAug 20262025-11-06
MDXGModified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUsNCT06600724Not applicableRecruitingAug 20262024-09-19
MIRMA Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)NCT07298330Phase 3Active, not recruitingAug 20262026-06-29
MMSIPREEMIE: Study for Treatment of PDA in Premature InfantsNCT06587282Not applicableActive, not recruitingAug 20262026-05-15
NRIXA Study of NX-1607 in Adults With Advanced MalignanciesNCT05107674Phase 1Recruiting2026-08-312025-09-09
NTRALAMBDA 002 (Lung Registry) StudyNCT05170425—Active, not recruitingAug 20262025-05-22
NVOA Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in ChinaNCT07456774—Enrolling by invitation2026-08-312026-05-20
PFEA Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.NCT07543380Phase 3Recruiting2026-08-312026-06-02
PFEA Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy AdultsNCT07594769Phase 1Recruiting2026-08-312026-06-10
RADXSafety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid TumorsNCT05799274Phase 1RecruitingAug 20262026-07-17
RCUSA Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the BodyNCT05568095Phase 3Active, not recruitingAug 20262026-07-31
RIGLStudy of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)NCT05308264Phase 1/2RecruitingAug 20262026-08-10
SGHTOMNI 3.1 Surgical System in Subjects With Primary Open-Angle GlaucomaNCT06991270Not applicableRecruiting2026-08-312026-01-14
SNYValidation of Chlamydia Diagnostic Codes in TriNetX US EHR DataNCT07094373—Recruiting2026-08-312026-07-10
TMDXOCS Heart EXPAND + CAP Continued Follow-UpNCT05096299—Active, not recruitingAug 20262025-04-09
VSTMStudy of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic CancerNCT05669482Phase 1/2Active, not recruiting2026-08-312025-09-02
XENEA Randomized Study of Azetukalner Versus Placebo in Major Depressive DisorderNCT06775379Phase 3RecruitingAug 20262026-08-03
ZBHPMCF Study on the Safety, Performance and Clinical Benefits Data of the ComposiTCPNCT07080450—RecruitingAug 20262026-02-03

September 2026 126

TickerStudyPhaseStatusPrimary completionUpdated
ARDXStudy to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 YearsNCT05643534Phase 3Active, not recruiting2026-09-012026-06-04
INCYTafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL PatientsNCT04824092Phase 3Active, not recruiting2026-09-012026-04-01
NVOA Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseaseNCT06717698Phase 2Recruiting2026-09-012026-03-11
PFETACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)NCT05548127Phase 1/2Active, not recruiting2026-09-012026-02-10
PFEA Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial HypertensionNCT06137742Phase 1/2Active, not recruiting2026-09-022026-05-19
AMGNComparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose.NCT07545226Phase 1Active, not recruiting2026-09-032026-07-20
AZNA Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain CancerNCT03423628Phase 1Active, not recruiting2026-09-032026-07-17
INCYA Study to Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of Multiple Doses of Oral Povorcitinib or Topical Ruxolitinib Cream in Healthy Adult ParticipantsNCT07588139Phase 1Recruiting2026-09-032026-06-03
NVOA Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body WeightNCT07605052Phase 1Active, not recruiting2026-09-032026-08-17
PFEA Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy AdultsNCT07597928Phase 1Recruiting2026-09-032026-06-15
SNYEfficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus ErythematosusNCT05039840Phase 2Active, not recruiting2026-09-032026-08-06
BMYA Study of BMS-986490 With or Without Bevacizumab in Advanced Solid TumorsNCT06730750Phase 1/2Recruiting2026-09-052026-07-02
HLUN-B.COA Study With Eptinezumab in Adolescents (12-17 Years) With Chronic MigraineNCT04965675Phase 3Recruiting2026-09-052026-07-14
IBAB.BRClinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei)NCT07137195Not applicableActive, not recruiting2026-09-052026-02-27
MDAIReal-World Evaluation of AI Enabled Multi-Spectral Imaging (MSI) for AMD Biomarker DetectionNCT07446582—Recruiting2026-09-052026-03-11
ALK-B.COA Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65NCT07060885Phase 3Active, not recruiting2026-09-062026-07-20
AZNA Phase I, Cross-over Study Comparing the Relative Bioavailability of Laroprovstat Plus Ezetimibe Fixed Combination Drug Products Versus Their Single Therapy Products in Healthy AdultsNCT07622433Phase 1Active, not recruiting2026-09-072026-07-28
PFEA Study to Learn About How Food Affects the Uptake of Study Medicine Prifetrastat Into the Blood in Healthy AdultsNCT07731100Phase 1Not yet recruiting2026-09-102026-07-28
SNYAgalsidase Beta Long-Term Treatment Outcome for Fabry Disease Patients With IVS4 Mutation in TaiwanNCT06052800—Active, not recruiting2026-09-102026-05-15
NVOA Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 DiabetesNCT07087795Phase 1Active, not recruiting2026-09-122026-08-13
PFEA Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding WomenNCT07153159Phase 1Recruiting2026-09-122026-04-07
000100.KSBioequivalence Study Between YHP2508C and YHR2603 in Healthy SubjectsNCT07584304Phase 1Not yet recruiting2026-09-152026-05-13
HLUN-B.COA Trial of Lu AG13909 in Adult Participants With Cushing's DiseaseNCT06471829Phase 2Recruiting2026-09-152026-06-12
PFEA Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without DiabetesNCT06924320Phase 1/2Recruiting2026-09-152026-06-01
AZNA Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234NCT07220954Phase 1Active, not recruiting2026-09-172026-08-13
VRTXAn Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney TransplantNCT06832410Phase 3Recruiting2026-09-172026-03-23
SNYiGlarLixi CGM Study in Chinese T2D Individuals After OADsNCT06671587Phase 4Recruiting2026-09-182026-03-17
CRDLCardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)NCT06708299Phase 3Recruiting2026-09-212026-08-13
PFEA Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.NCT06587035—Recruiting2026-09-212026-08-14
MRNAStudy to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of AgeNCT05992935Phase 1/2Active, not recruiting2026-09-222026-04-03
ONCA Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström MacroglobulinemiaNCT05952037Phase 2Active, not recruiting2026-09-222026-01-02
PFEKorean Post-marketing Surveillance for Xeljanz XRNCT04876781—Recruiting2026-09-222026-08-03
SNYReal-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational StudyNCT05991323—Active, not recruiting2026-09-222025-09-16
AZNA Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.NCT06995820Phase 1Recruiting2026-09-232026-05-15
PFEStudy to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid TumorsNCT04557449Phase 2Active, not recruiting2026-09-232025-10-01
PFEKorean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth HormoneNCT05509894—Active, not recruiting2026-09-232026-01-27
VIREffect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434NCT05484206Phase 1Recruiting2026-09-252025-06-13
BIIBA Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus ErythematosusNCT04961567Phase 3Active, not recruiting2026-09-272026-01-29
ONCA Study to Investigate the Relative Bioavailability and Food Effect of Tablet for Oral Suspension of Sonrotoclax in Healthy AdultsNCT07628881Phase 1Recruiting2026-09-272026-07-09
AZNA Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2NCT07143604Phase 2Active, not recruiting2026-09-282026-06-17
INCYA Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell CarcinomaNCT05888844Phase 2Active, not recruiting2026-09-282026-08-17
MLTXAn Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)NCT06768671Phase 3Active, not recruiting2026-09-282026-05-06
OCGNA Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt DiseaseNCT05956626Phase 2/3Active, not recruiting2026-09-282026-07-31
SNYStudy to Compare the Plasma Concentration of Belumosudil Given as an Oral Suspension and as a Tablet to Healthy Adult Male ParticipantsNCT07726914Phase 1Not yet recruiting2026-09-282026-07-24
SNYLong-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical StudyNCT06033833Phase 2Active, not recruiting2026-09-292026-05-20
4568.TA Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)NCT06362252Phase 1/2Recruiting2026-09-302026-02-06
ABBVA Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid TumorsNCT02988960Phase 1Active, not recruitingSep 20262026-01-09
ABBVA Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabNCT06100744Phase 3RecruitingSep 20262026-07-31
ABBVA Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male ParticipantsNCT06953934Phase 1Active, not recruitingSep 20262026-06-29
ABBVA Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease and Ulcerative Colitis in Real World SettingNCT07421258—RecruitingSep 20262026-03-27
ABBVA Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injection Moves Through the Body of Healthy Adult ParticipantsNCT07604558Phase 1RecruitingSep 20262026-06-24
ABBVA Study to Evaluate How Multiple Doses of Itraconazole Interacts With Nacresertib in Healthy Adult ParticipantsNCT07649954Phase 1RecruitingSep 20262026-07-23
ABVXStudy to Evaluate Pharmacokinetics, Relative Bioavailability, Palatability of Obefazimod Minitablet FormulationNCT07453784Phase 1RecruitingSep 20262026-04-06
ALKSStudy to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I DisorderNCT05303064Phase 3RecruitingSep 20262026-08-14
APGEA Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With AsthmaNCT06920901Phase 1Active, not recruitingSep 20262026-02-17
ARWRStudy of ARO-DIMERPA in Adult Participants With Mixed HyperlipidemiaNCT07223658Phase 1/2Recruiting2026-09-302026-08-18
AVIRC-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCVNCT06868264Phase 3Active, not recruitingSep 20262025-12-05
AZNA Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung CancerNCT05221840Phase 3Active, not recruiting2026-09-302026-06-18
AZNDurvalumab Plus Tremelimumab as First-line Treatment in Chinese Patients With uHCCNCT05557838Phase 3Active, not recruiting2026-09-302026-06-26
AZNA Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT06417814Phase 3Recruiting2026-09-302026-05-14
AZNClinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry StudyNCT06521229—Recruiting2026-09-302026-04-20
AZNReal-world Study Assessing Efficacy of TezepeLumaB in Patients With Severe Asthma Regardless of Phenotype in RussiaNCT06566885—Active, not recruiting2026-09-302026-05-12
AZNAn Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma PatientsNCT06605885—Active, not recruiting2026-09-302026-08-12
AZNA Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With DyslipidaemiaNCT07218900Phase 2Active, not recruiting2026-09-302026-06-04
AZNPrevalence, Clinical Characteristics, Progression, and Management of Neurofibromatosis Type 1 in Egypt (NF1-Egy)NCT07221331—Recruiting2026-09-302026-08-12
AZNStudy for Assessing the Prevalence of Airflow Limitation in Outpatients With History of Smoking Attending Cardiology ClinicsNCT07315958—Recruiting2026-09-302026-08-14
AZNObservational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in BrazilNCT07370194—Recruiting2026-09-302026-07-24
AZNHER2-positive Metastatic Breast Cancer in KazakhstanNCT07593196—Not yet recruiting2026-09-302026-05-18
BIIBA Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus ErythematosusNCT04895241Phase 3Active, not recruiting2026-09-302026-02-10
BJDXMulticenter Symphony IL-6 Monitoring Sepsis ICU Validation StudyNCT06654895—Active, not recruiting2026-09-302026-08-19
BMYA Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid TumorsNCT05888831Phase 1/2Active, not recruiting2026-09-302025-06-11
BMYDemographics, Clinical Characteristics and Outcomes in Resected Non-Small Cell Lung Cancer Patients Receiving Immunotherapy in Europe and CanadaNCT07718139—Active, not recruiting2026-09-302026-07-21
CCCCStudy to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple MyelomaNCT04756726Phase 1Active, not recruiting2026-09-302026-03-25
CDNAHeartCare Immuno-optimization in Cardiac Allografts (MOSAIC)NCT05459181Not applicableNot yet recruitingSep 20262024-10-23
CGEMA Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple MyelomaNCT06381141Phase 1Active, not recruitingSep 20262025-09-18
CHRSStudy of CHS-114 in Participants With Advanced Solid TumorsNCT05635643Phase 1Active, not recruiting2026-09-302026-08-12
CL6-month Clinical Investigation Assessing the Efficacy of an Antimicrobial Mouthrinse in Reducing Established Plaque and Improving Gum HealthNCT07414173Phase 4RecruitingSep 20262026-02-17
CLA Study to Investigate Stannous Fluoride Containing Toothpaste on Antibacterial Effects in the Different Regions of the MouthNCT07458464Phase 3Not yet recruitingSep 20262026-07-28
CLClinical Study to Collect and Analyze Dental Plaque and Oral Health Measures in a Population With High Plaque/Low Gingivitis and High Plaque/High GingivitisNCT07614490Phase 4Recruiting2026-09-302026-05-29
CLComparative Efficacy of Different Dentin Occluding Toothpaste TechnologiesNCT07664592Phase 3RecruitingSep 20262026-08-07
CORTA Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)NCT06108219Phase 2Active, not recruitingSep 20262026-05-08
CORTTwo Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid MalignanciesNCT07276373Phase 1/2RecruitingSep 20262026-08-19
CYTKAMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEFNCT06793371Phase 2RecruitingSep 20262026-05-29
DSGNDT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal DystrophyNCT07024693Phase 2RecruitingSep 20262025-12-29
EWTXPhase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)NCT05291091Phase 2Active, not recruitingSep 20262026-07-31
GILDStudy of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus InfectionNCT02932150Phase 2Active, not recruitingSep 20262026-06-18
GILDStudy of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)NCT05186974Phase 2Active, not recruitingSep 20262026-02-11
GKOSEvaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex BlepharitisNCT07400965Phase 2RecruitingSep 20262026-02-27
GPCRAleniglipron Phase 2 in Type 2 Diabetes MellitusNCT07400588Phase 2Active, not recruitingSep 20262026-04-27
HLNA Study to Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml in an Oral Liquid Suspension Fixed-Dose Combination Product in Children Aged 6 to 11 YearsNCT07632274Phase 1RecruitingSep 20262026-06-30
HLUN-B.COA Trial of Lu AG13909 in Participants With Congenital Adrenal HyperplasiaNCT05669950Phase 1/2Recruiting2026-09-302026-03-09
HTFLThe NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCINCT07479433—Recruiting2026-09-302026-03-23
IBRXA Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder CancerNCT02138734Phase 1/2Active, not recruiting2026-09-302026-03-31
IRONStudy of Bitopertin in Participants With EPP or XLP (APOLLO)NCT06910358Phase 3Active, not recruitingSep 20262026-08-12
ISRGCoSMAP Trial: SP-EA vs MP-TA Robot-Assisted Radical ProstatectomyNCT07666217—Active, not recruiting2026-09-302026-06-24
KPTIA Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated MyelofibrosisNCT04562870Phase 2Active, not recruitingSep 20262026-07-02
LLYA Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesNCT05536804Phase 2Active, not recruitingSep 20262026-05-08
LLYA Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)NCT06280703Phase 1RecruitingSep 20262026-01-20
LLYA Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)NCT06339008Phase 3Active, not recruitingSep 20262026-07-22
LLYA Study to Compare Two Different Sleep Tests in Participants With No Symptoms or Early Symptoms of Alzheimer's DiseaseNCT07485153—Not yet recruitingSep 20262026-03-20
LLYA Study of Food Effect on Tersolisib (LY4064809) in Healthy ParticipantsNCT07662798Phase 1Active, not recruitingSep 20262026-08-19
MAZEA Phase 2 Study of MZE829 in Adults With APOL1 Kidney DiseaseNCT06830629Phase 2RecruitingSep 20262026-07-27
MRNAA Retrospective Study to Characterize Participants With Propionic AcidemiaNCT05769621—Recruiting2026-09-302026-02-05
NVOCharacteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.NCT07154238—Enrolling by invitation2026-09-302025-11-25
NVOKorean Real-world Study on MASLD/MASH Outcomes.NCT07739901—Active, not recruiting2026-09-302026-07-31
NYXH.BRSafety and Effectiveness of the Genio® bilAteral Stimulation for Treatment of Complete Concentric CollapsE and OSA.NCT05592002Not applicableActive, not recruitingSep 20262025-09-05
ONCA Study to Investigate the Effect of the CYP3A Inducer Phenytoin and the CYP3A Inhibitor Itraconazole on the Pharmacokinetics of BGB-58067 in Healthy ParticipantsNCT07590102Phase 1Recruiting2026-09-302026-07-22
ORICStudy of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 AlterationNCT05315700Phase 1/2RecruitingSep 20262025-08-05
PCSAA Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast CancerNCT06568692Phase 2RecruitingSep 20262025-06-19
PFEKorea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic ArthritisNCT05754710—Recruiting2026-09-302026-08-03
RGNXAFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)NCT05693142Phase 2/3Active, not recruitingSep 20262026-07-21
RXSTLong-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment StudyNCT07347379—Enrolling by invitationSep 20262026-08-12
SGHTA Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX)NCT06948773Not applicableActive, not recruiting2026-09-302026-07-07
SLNStudy to Assess SLN124 in Patients With Polycythemia VeraNCT05499013Phase 1/2Active, not recruitingSep 20262025-12-19
SNDXMAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)NCT06132256Phase 2Active, not recruitingSep 20262026-03-27
SNNPost-Market Clinical Study to Evaluate the Safety and Effectiveness of REFLEX ULTRA 45 for Coblation Inferior Turbinate Reduction in ChinaNCT07025304Not applicableRecruiting2026-09-302026-01-07
SNYStudy in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in SpainNCT06415175—Active, not recruiting2026-09-302026-02-25
SNYPharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy ParticipantsNCT07646548Phase 1Active, not recruiting2026-09-302026-07-21
SUPNOpen-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)NCT02736656Phase 3Active, not recruitingSep 20262026-07-15
TNGXStudy of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid TumorsNCT05887492Phase 1/2Active, not recruitingSep 20262026-07-06
TRAWStudy of TRX-100 Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy VolunteersNCT07526506Phase 1RecruitingSep 20262026-08-03
TYRASafety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene AlterationsNCT06160752Phase 1Active, not recruitingSep 20262026-08-05
VERAMonthly Dosing of Atacicept in IgANNCT07020923Phase 2Active, not recruitingSep 20262026-04-13
VNDAEvaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)NCT04652882Phase 3Active, not recruitingSep 20262026-07-27
VNDASafety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe OnychomycosisNCT07065773Phase 2Active, not recruitingSep 20262026-02-04
VNDAAn Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry EyeNCT07179055Phase 2RecruitingSep 20262025-09-17

October 2026 118

TickerStudyPhaseStatusPrimary completionUpdated
AMGNSingle and Multiple Ascending Dose Study of AMG 513 in Participants With ObesityNCT06585462Phase 1Recruiting2026-10-012026-06-22
AZNA Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering DrugsNCT05663515—Recruiting2026-10-012026-08-04
BMYA Real-World Study of β-Thalassemia Major Treatment With Luspatercept in TaiwanNCT06596642—Active, not recruiting2026-10-012025-06-04
BMYEvaluation of Esophagogastric Cancer Treatment With Nivolumab in Daily Clinical PracticeNCT07663786—Active, not recruiting2026-10-012026-06-23
COCPA Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain VirusNCT07198139Phase 1/2Recruiting2026-10-012026-02-17
NTRAThe PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)NCT04091984—Active, not recruiting2026-10-012024-08-06
NVOA Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and InflammationNCT06200207Phase 3Active, not recruiting2026-10-012026-07-31
PFEImpact and Effectiveness of ABRYSVO® Vaccination During PregnancyNCT06647654—Active, not recruiting2026-10-012026-05-15
AZNAZD5305 hADME in Patients With Advanced Solid MalignanciesNCT06713369Phase 1Recruiting2026-10-022026-06-24
PSTVMultiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal MetastasesNCT07098806Phase 1Recruiting2026-10-022025-08-01
MRNAA Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and AdultsNCT05164094Phase 1/2Active, not recruiting2026-10-052026-05-06
SOBI.STA Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia MyelofibrosisNCT03165734Phase 3Active, not recruiting2026-10-052026-04-30
BMYA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary FibrosisNCT06003426Phase 3Active, not recruiting2026-10-062026-03-24
REGNStudy to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)NCT02612454Phase 3Active, not recruiting2026-10-072026-05-29
AMGNEvaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate CancerNCT06555796Phase 1Active, not recruiting2026-10-082026-01-26
AZNA Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese PopulationNCT06419413—Recruiting2026-10-082026-08-18
INCYStudy to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)NCT06958211Phase 3Active, not recruiting2026-10-092026-07-08
INCYStudy to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)NCT06959225Phase 3Active, not recruiting2026-10-092026-07-28
PFEA Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.NCT06447662Phase 1Active, not recruiting2026-10-092026-07-22
BMYA Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple MyelomaNCT05372354Phase 1/2Recruiting2026-10-122025-09-05
REGNA Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor TreatmentNCT05133531Phase 3Active, not recruiting2026-10-122026-04-30
MRNAA Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy ParticipantsNCT05831111Phase 1Active, not recruiting2026-10-132026-08-11
SNYA Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal PolypsNCT06834347Phase 3Active, not recruiting2026-10-142026-05-20
AZNRetention Rate of Acalabrutinib in a Non-interventional SettingNCT05645172—Active, not recruiting2026-10-152025-12-01
AZNA Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES)NCT07717840Phase 1/2Recruiting2026-10-152026-07-21
SLDBMicrodystrophin Gene Transfer Study in Adolescents and Children With DMDNCT03368742Phase 1/2Active, not recruiting2026-10-152026-08-10
AZNBenralizumab Airway Remodeling Study in Severe Eosinophilic AsthmaticsNCT03953300Phase 4Active, not recruiting2026-10-192026-07-28
BMYA Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)NCT05617677Phase 3Active, not recruiting2026-10-192025-12-03
BMYA Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus ErythematosusNCT05620407Phase 3Active, not recruiting2026-10-192025-12-02
INCYA Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)NCT06516952Phase 3Active, not recruiting2026-10-192026-05-28
INCYA Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)NCT06516965Phase 3Active, not recruiting2026-10-192026-04-14
INCYA Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous Administration in Healthy Adult ParticipantsNCT07448155Phase 1Recruiting2026-10-192026-07-08
PFEA Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic DermatitisNCT05995964Phase 2Recruiting2026-10-192026-05-04
TEMTempus Priority Study: A Pan-tumor Observational StudyNCT05179824—Active, not recruiting2026-10-192025-05-06
4568.TFirst-in-Human Study of DS-3939a in Participants With Advanced Solid TumorsNCT05875168Phase 1/2Recruiting2026-10-202026-08-12
BIIBA 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus ErythematosusNCT05531565Phase 2/3Active, not recruiting2026-10-202026-08-13
AZNA Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy ParticipantsNCT07290283Phase 1Recruiting2026-10-212026-07-31
AMGNA Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom StateNCT06245408Phase 3Active, not recruiting2026-10-222026-01-08
AZNA Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRASNCT06008093Phase 2Active, not recruiting2026-10-232026-07-02
NVOPatient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in GermanyNCT07653139—Not yet recruiting2026-10-262026-06-17
AZNStudy of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary CancerNCT05775159Phase 2Active, not recruiting2026-10-272026-07-02
AZNThe Prevalence of COPD in Patients With Cardiovascular Disease and the Benefit of Cardiopulmonary Co-managementNCT06909773Not applicableRecruiting2026-10-282026-06-26
AZNInvestigating the Effect of Itraconazole on the Pharmacokinetics of AZD4144 in Healthy ParticipantsNCT07685600Phase 1Not yet recruiting2026-10-282026-07-06
SNYA Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)NCT04848779—Active, not recruiting2026-10-282026-06-24
AZNPost-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary DiseaseNCT06531798Phase 4Recruiting2026-10-302026-07-22
CORTEvaluating the Pharmacokinetics and Safety of MiricorilantNCT07553663Phase 1Recruiting2026-10-302026-05-26
MBXA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With ObesityNCT07142707Phase 1Recruiting2026-10-302026-06-09
NVORegulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in KoreaNCT05714683—Not yet recruiting2026-10-302025-12-05
NYXH.BRA Post-market Clinical Follow up of the Genio® System for the Treatment of Obstructive Sleep Apnea in AdultsNCT04031040Not applicableActive, not recruiting2026-10-302026-03-04
PFEA Study to Learn About How Well the Prevnar 20 Vaccine Works for Pneumonia in People Who Are 65 Years and OlderNCT06782282—Active, not recruiting2026-10-302026-04-22
VRTXA Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination TherapyNCT05444257Phase 3Active, not recruiting2026-10-302026-07-21
4568.TAssessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic ImpairmentNCT06740799Phase 1Recruiting2026-10-312026-04-01
ABBVA Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic DermatitisNCT05081557—Active, not recruitingOct 20262025-08-14
ABBVPivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMDNCT05407636Phase 3Active, not recruitingOct 20262026-08-03
ABBVStudy to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult ParticipantsNCT07680686Phase 1RecruitingOct 20262026-08-10
ABOSA Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)NCT06335173Phase 2Active, not recruitingOct 20262025-10-27
ADAGADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid TumorsNCT05405595Phase 1/2Recruiting2026-10-312026-01-07
AKBASAD and MAD Study of AKB-9090 in Healthy Adult ParticipantsNCT07429006Phase 1RecruitingOct 20262026-04-13
AMGNAnvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).NCT06333951Phase 1Active, not recruiting2026-10-312026-05-28
AMGNA Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)NCT06360354Phase 1Active, not recruiting2026-10-312026-06-01
AMGNA Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)NCT06593522Phase 2Active, not recruiting2026-10-312026-05-28
ANNXA Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)NCT06510816Phase 3Active, not recruiting2026-10-312026-05-04
AZNOndexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)NCT05454787—Recruiting2026-10-312026-07-28
AZNPhase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian PatientsNCT06429761Phase 4Recruiting2026-10-312025-11-24
AZNCapivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese PatientsNCT06635447Phase 3Active, not recruiting2026-10-312026-08-17
BCRXA Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725NCT06539507Phase 1RecruitingOct 20262026-06-16
BIIBA Study Utilising Data From European Union (EU) National Multiple Sclerosis (MS) Registries to Assess the Incidence of Anti-Natalizumab Antibody Among Participants Who Receive Subcutaneous Administration of Natalizumab for Treatment of Relapsing-remitting Multiple Sclerosis (RRMS)NCT05925049—Active, not recruiting2026-10-312026-05-13
BMYA Rollover Study of CC-122NCT05688475Phase 1Active, not recruiting2026-10-312026-05-11
BMYAsia Myelodysplastic Syndrome (MDS) RegistryNCT07355478—Not yet recruiting2026-10-312026-02-13
BNTXA Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes LesionsNCT05432583Phase 1Active, not recruitingOct 20262025-10-20
BSXA Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBMNCT05303467Phase 1Recruiting2026-10-312026-07-31
BSXcOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-AsiaNCT06686485—Recruiting2026-10-312026-07-23
CBLLCeribell Delirium Monitor Outcomes Pilot StudyNCT07449416Not applicableRecruitingOct 20262026-07-22
CLClinical Study to Evaluate Remineralization Using an in Situ Model.NCT07625670Phase 3Not yet recruitingOct 20262026-06-04
CLDXA Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous UrticariaNCT06445023Phase 3Active, not recruitingOct 20262026-03-25
CLDXA Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)NCT06455202Phase 3Active, not recruitingOct 20262026-03-25
CORTDazucorilant in Patients With Amyotrophic Lateral SclerosisNCT05407324Phase 2RecruitingOct 20262026-06-16
CRNXA Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's SyndromeNCT05804669Phase 1/2Active, not recruitingOct 20262026-08-19
GEHCPortrait Mobile Monitoring Solution V2.0 External EvaluationNCT07309809Not applicableNot yet recruitingOct 20262026-06-10
GEHCNMT EasyFit Sensor and CableNCT07394140Not applicableRecruiting2026-10-312026-07-08
GILDStudy of Sacituzumab Govitecan in Patients With Solid TumorNCT05119907Phase 2Active, not recruitingOct 20262025-11-17
GILDStudy of GS-4528 in Adults With Solid TumorsNCT05840224Phase 1Active, not recruitingOct 20262026-07-27
HLNA Study to Investigate the Efficacy of an Experimental Dentifrice Containing Stannous Fluoride in Improving Gingival HealthNCT07704905Not applicableRecruitingOct 20262026-08-12
HNGEA Comprehensive Digital Care Program for Migraine ManagementNCT07642414Not applicableRecruitingOct 20262026-06-16
IBAB.BRClinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Sichuan)NCT07152353Not applicableActive, not recruitingOct 20262026-01-07
IBAB.BRClinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Shenzhen)NCT07153094Not applicableActive, not recruitingOct 20262026-01-16
IBRXA Study to Assess Anktiva in Patients With Long Covid-19.NCT07108036Phase 2RecruitingOct 20262026-05-11
IDYAA Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsNCT05787587Phase 1Active, not recruitingOct 20262026-07-13
IMCRSafety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint InhibitorsNCT04262466Phase 1/2Active, not recruitingOct 20262026-03-06
IRONStudy of DISC-0974-201 in Participants With IBD and AnemiaNCT07368972Phase 2RecruitingOct 20262026-08-03
JANXStudy of JANX011 in Healthy Adult Volunteers to Assess Safety and Tolerability.NCT07291323Early Phase 1RecruitingOct 20262026-04-23
JBIOA Phase 1 Study of JADE101 in Healthy ParticipantsNCT07059312Phase 1Active, not recruitingOct 20262025-12-18
LLYA Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)NCT04088396Phase 3Active, not recruitingOct 20262026-08-11
LLYEffect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)NCT06297603Phase 3Active, not recruitingOct 20262026-07-20
LLYA Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal FunctionNCT07426380Phase 1Active, not recruitingOct 20262026-08-19
LLYA Study of Eloralintide (LY3841136) in Healthy ParticipantsNCT07701083Phase 1Not yet recruitingOct 20262026-07-14
LLYA Study of LY4268989 (MORF 057) in Healthy ParticipantsNCT07707375Phase 1Not yet recruitingOct 20262026-07-16
MIRMEvaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)NCT06553768Phase 3Active, not recruitingOct 20262026-08-11
NTHIA Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain TumorsNCT06357377Phase 1Not yet recruitingOct 20262026-01-14
NTRAProspera Test Evaluation in Cardiac Transplant (ProTECT)NCT05205551—Active, not recruiting2026-10-312025-05-22
OGNTapinarof for the Treatment of Plaque Psoriasis in Pediatric SubjectsNCT05172726Phase 3Active, not recruitingOct 20262026-04-17
OLMAOP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerNCT06016738Phase 3Active, not recruiting2026-10-312026-08-13
PHATA Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 WeeksNCT06851559Phase 2Active, not recruitingOct 20262026-06-29
PHIL.MISafety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed GlioblastomaNCT04443010Phase 1/2RecruitingOct 20262023-10-10
PLSENS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX SystemNCT07018596Not applicableRecruitingOct 20262026-05-06
REPLStudy of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid TumorsNCT04336241Phase 1Active, not recruiting2026-10-312026-02-27
RMDRegistry Study on Prescription, Patient Pathways, Therapy Efficacy and Usage of Mandibular Advancement Devices in Obstructive Sleep Apnea - PATT-OSA RegistryNCT03924817—Active, not recruiting2026-10-312026-08-13
RMDCircadian Rhythm Monitoring StudyNCT07336654Not applicableNot yet recruitingOct 20262026-05-19
RMDExploration of Current and New Technologies for Accuracy of Diagnosing OSANCT07485582—Not yet recruitingOct 20262026-08-19
RYTMA Study of Setmelanotide in Patients With Prader-Willi SyndromeNCT06772597Phase 2Active, not recruiting2026-10-312026-02-12
SRPTA Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)NCT03992430Phase 3Active, not recruiting2026-10-312026-02-27
SYREA Study of SPY072 in Rheumatic DiseaseNCT07148414Phase 2Active, not recruiting2026-10-312026-06-05
TGTXA Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast MilkNCT06143514—Recruiting2026-10-312026-07-20
TGTXA Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS)NCT07211633Phase 3Active, not recruiting2026-10-312026-07-17
TMDXOCS DCD Heart + CAP Continued Follow-UpNCT05741723—Active, not recruitingOct 20262025-09-09
VNDAEvaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled HypertensionNCT07090161Phase 2RecruitingOct 20262026-02-27
XENEA Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)NCT05716100Phase 3RecruitingOct 20262026-05-14
ZBHHi-Fatigue G Bone Cement Retrospective StudyNCT06699134—RecruitingOct 20262025-12-02

November 2026 28

TickerStudyPhaseStatusPrimary completionUpdated
BMYA Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I DisorderNCT06951698Phase 3Recruiting2026-11-012026-07-27
CRBPFirst-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.NCT06603844Phase 1/2Recruiting2026-11-012025-06-03
ERASA Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid TumorsNCT04866134Phase 1/2Active, not recruiting2026-11-012026-06-22
EWALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt SystemNCT05686317Not applicableActive, not recruiting2026-11-012026-06-04
SRRKLong-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of ApitegromabNCT05626855Phase 3Active, not recruiting2026-11-012025-05-25
AZNA Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus ErythematosusNCT06015737Phase 3Active, not recruiting2026-11-022026-07-29
AZNOverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR AmyloidosisNCT06355934—Recruiting2026-11-022026-08-11
BMYA Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)NCT06951711Phase 3Recruiting2026-11-022026-08-18
DXCMContinuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudi ArabiaNCT07603284Phase 4Active, not recruiting2026-11-022026-05-22
REGNA Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 MelanomaNCT06190951Phase 2Active, not recruiting2026-11-022026-02-10
INCYRollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)NCT04509700Phase 2Active, not recruiting2026-11-052026-06-25
REGNExtension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)NCT04515524—Active, not recruiting2026-11-052026-03-27
PFESafety and Efficacy of Xalkori ROS1NCT03375242—Active, not recruiting2026-11-062026-03-30
SNYA Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal PolypsNCT06834360Phase 3Active, not recruiting2026-11-062026-06-02
AZNTrastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)NCT04784715Phase 3Active, not recruiting2026-11-112026-07-30
AZNGYNGHER - HER2 Expression in Gynecological Malignancies: a Brazilian CohortNCT07101081—Recruiting2026-11-112026-07-22
AZNA Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic ImpairmentNCT07343960Phase 1Recruiting2026-11-112026-07-02
PGENPRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical CancerNCT06157151Phase 2Recruiting2026-11-112026-04-23
4523.TA Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy ParticipantsNCT07766369Phase 1Not yet recruiting2026-11-122026-08-14
PFEEvaluating the Benefits of RSV Maternal Vaccination Using a Scottish National DatasetNCT07235397—Not yet recruiting2026-11-132026-07-01
REGNA Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced CancersNCT04626635Phase 1/2Active, not recruiting2026-11-132026-07-02
REGNStudy of Olatorepatide in Adult Participants Living With Overweight or Obesity in the USNCT07431086Phase 2Active, not recruiting2026-11-132026-06-17
ACHVPhase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E CigarettesNCT07392125Phase 3Not yet recruiting2026-11-152026-02-06
AMGNA Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes MellitusNCT07160257Phase 1Active, not recruiting2026-11-152026-06-12
AZNNational Acalabrutinib Observational StudyNCT05437250—Active, not recruiting2026-11-152026-05-28
AZNAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2NCT06219941Phase 2Recruiting2026-11-172026-07-29
BMYA Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants.NCT07283263Phase 1Recruiting2026-11-172026-01-07
SOBI.STA Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa ProphylaxisNCT06752850Phase 4Active, not recruiting2026-11-172026-04-30

Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.

Related →Calendar (CAL)Screener (SCR)Watchlist (WL)